Overview * Tredegar ( TG ) Q3 net income from continuing ops rises to $7.1 mln from a loss last year * Company's Q3 sales increase 33% yr/yr due to higher volume and metal cost pass-through * EBITDA from ongoing operations for Aluminum Extrusions rises significantly yr/yr Outlook * Company evaluating cost reduction opportunities to be realized in 2026 *...

HOUSTON and THE WOODLANDS, Texas, Nov. 07, 2025 (GLOBE NEWSWIRE) -- IES Holdings, Inc. ( IESC ) (“IES”) and Gulf Island Fabrication, Inc. ( GIFI ) (“Gulf Island”) today announced that they have entered into a definitive agreement, providing for the acquisition of Gulf Island, a leading steel fabricator and service provider to the industrial, energy and government sectors, by...

LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of...

Nov 7 (Reuters) - Rhythm Pharmaceuticals ( RYTM ) said on Friday the U.S. Food and Drug Administration has extended the review period for expanded approval of its drug to treat a rare form of obesity, caused due to brain damage, by three months. The FDA extended the review of Imcivree from December 20 to March 20, 2026, the company...